Table 1.
Patient characteristics
Neoadjuvant ( n = 80) | Adjuvant ( n = 90) | P | |
---|---|---|---|
Age (years) | 60 (21–74) | 59 (29–82) | 0.762 |
Sex | 0.982 | ||
Male | 63 (78.8%) | 71 (78.9%) | |
Female | 17 (21.2%) | 19 (21.1%) | |
BMI (kg/m2) | 23.8 | 23.6 | 0.709 |
> 25 | 26 (32.5%) | 29 (32.2%) | |
Tumor location | 0.135 | ||
GEJ | 32 (40.0%) | 21 (23.3%) | |
Body | 15 (18.8%) | 22 (24.5%) | |
Distal | 32 (40.0%) | 45 (50.0%) | |
Total | 1 (1.2%) | 2 (2.2%) | |
Clinical TNM stage | 0.172 | ||
II | 4 | 10 | |
III | 76 | 80 |
BMI body mass index, GEJ gastroesophageal junction.